BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of The Spectranetics Corporation (“Spectranetics” or the “Company”) (NASDAQ:SPNC) concerning the recent disclosures regarding its lackluster earnings, and the Company’s and its officers’ possible violations of federal securities laws. Spectranetics investors are encouraged to contact Law Offices of Howard G. Smith to discuss the alleged wrongdoing, and steps investors can take to recover any losses caused by the Company’s alleged fraud.
Spectranetics produces and distributes medical devices that are used for treatment in cardiovascular patients. On July 23, 2015 after the market close, the Company reported a loss of 17 cents per share, and losses, adjusted for non-recurring gains, of 22 cents per share, on revenue of $61.7 million. In a conference call to discuss its quarterly results, the Company lowered its full year 2015 revenue guidance to a range of $240 million to $250 million from its previous guidance of $258 million. On this news Spectranetics shares fell over 34%, or $8.53 per share to close on July 24, 2015 at $16.30 per share.
If you purchased Spectranetics shares, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.